Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Soleno Therapeutics (SLNO) Consolidated Net Income: 2013-2024

Historic Consolidated Net Income for Soleno Therapeutics (SLNO) over the last 9 years, with Dec 2024 value amounting to -$175.8 million.

  • Soleno Therapeutics' Consolidated Net Income rose 54.35% to -$544,000 in Q4 2017 from the same period last year, while for Dec 2017 it was -$3.6 million, marking a year-over-year increase of 52.99%. This contributed to the annual value of -$175.8 million for FY2024, which is 353.15% down from last year.
  • As of FY2024, Soleno Therapeutics' Consolidated Net Income stood at -$175.8 million, which was down 353.15% from -$38.8 million recorded in FY2023.
  • In the past 5 years, Soleno Therapeutics' Consolidated Net Income registered a high of -$24.1 million during FY2022, and its lowest value of -$175.8 million during FY2024.
  • For the 3-year period, Soleno Therapeutics' Consolidated Net Income averaged around -$79.6 million, with its median value being -$38.8 million (2023).
  • Data for Soleno Therapeutics' Consolidated Net Income shows a maximum YoY crashed of 353.15% (in 2024) over the last 5 years.
  • Soleno Therapeutics' Consolidated Net Income (Yearly) stood at -$24.1 million in 2022, then plummeted by 61.04% to -$38.8 million in 2023, then tumbled by 353.15% to -$175.8 million in 2024.